Understanding how a protein related to Alzheimer's disease functions

Mechanisms of APP ectodomain function

['FUNDING_OTHER'] · OKLAHOMA MEDICAL RESEARCH FOUNDATION · NIH-11120599

This study is looking at a protein related to Alzheimer's disease to understand how it works in the brain and affects thinking, with the hope that this knowledge could help develop new treatments for patients.

Quick facts

Phase['FUNDING_OTHER']
Study typeNih_funding
SexAll
SponsorOKLAHOMA MEDICAL RESEARCH FOUNDATION (nih funded)
Locations1 site (OKLAHOMA CITY, UNITED STATES)
Trial IDNIH-11120599 on ClinicalTrials.gov

What this research studies

This research investigates the role of the extracellular domain of the Amyloid Precursor Protein (APP), which is crucial in the development of Alzheimer's disease. The study aims to uncover how this protein interacts with other cellular components and its effects on cognitive functions. By exploring the mechanisms of ectodomain shedding, the research seeks to clarify how APP contributes to cellular signaling and potentially influences Alzheimer's pathology. Patients may benefit from insights gained that could lead to new therapeutic strategies for Alzheimer's disease.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk for developing it.

Not a fit: Patients with other forms of dementia unrelated to Alzheimer's may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that improve cognitive function in patients with Alzheimer's disease.

How similar studies have performed: Previous research has shown promising results in understanding the role of APP in Alzheimer's, suggesting that this approach could yield valuable insights.

Where this research is happening

OKLAHOMA CITY, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Alzheimer disease dementia, Alzheimer syndrome, Alzheimer's Disease

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.